Stay updated with breaking news from Juan jaen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
How Gilead deal, portfolio of cancer drugs is propelling Arcus - San Francisco Business Times bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
- Agreement expands upon Arcus's industry-leading portfolio of clinical-stage molecules in the adenosine axis - Arcus to be granted exclusive worldwide rights Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused ....